TNF Inhibitors May Dampen COVID-19 Severity TNF Inhibitors May Dampen COVID-19 Severity

Patients on a TNF inhibitor when contracting COVID-19 were less likely to require hospitalization. Conversely, patients on ≥ 10 mg of prednisone daily when infected were more likely to be hospitalized.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology News Source Type: news